sugammadex /kg

Pipeline

Status by Indication[3][1]

Clinical

Trials by Indication[1]

Neuromuscular Blockade6 trials

Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients

Completed·PPoitiers University Hospital·Phase 2·NCT02545595

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Completed·Merck & Co.·Phase 4·NCT03909165·145 enrolled

Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)

Completed·Merck & Co.·Phase 4·NCT03351608·288 enrolled

Show 3 more trials

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Recruiting·UUniversitas Padjadjaran·Phase 1/2·NCT06794450·60 enrolled

Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex

Completed·UUniversity Hospital, Antwerp·Phase 3·NCT01962298·75 enrolled

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Completed·Merck & Co.·Phase 4·NCT03346057·344 enrolled

Sugammadex3 trials

Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961)

Completed·Merck & Co.·Phase 3·NCT00421148·94 enrolled

Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children

Completed·SSeoul National University Hospital·Phase 2·NCT03943888·40 enrolled

Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children

Completed·SSeoul National University Hospital·Phase 2·NCT04347486·32 enrolled

Elderly Patients1 trial

Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy

Completed·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 3·NCT04854993·34 enrolled

Neuromuscular Block1 trial

Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients

Completed·UUniversity Hospital, Ghent·Phase 2·NCT01911520·40 enrolled

Hypersensitivity1 trial

Sugammadex Hypersensitivity Study (Study P06042)

Completed·Merck & Co.·Phase 1·NCT00988065·448 enrolled

Details

Drug Info

Related News